Cargando…

Early intervention in panic: randomized controlled trial and cost-effectiveness analysis

BACKGROUND: Panic disorder (PD) is a common, severe and persistent mental disorder, associated with a high degree of distress and occupational and social disability. A substantial proportion of the population experiences subthreshold and mild PD and is at risk of developing a chronic PD. A promising...

Descripción completa

Detalles Bibliográficos
Autores principales: Meulenbeek, Peter, Willemse, Godelief, Smit, Filip, van Balkom, Anton, Spinhoven, Philip, Cuijpers, Pim
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630960/
https://www.ncbi.nlm.nih.gov/pubmed/19038038
http://dx.doi.org/10.1186/1745-6215-9-67
_version_ 1782163886924890112
author Meulenbeek, Peter
Willemse, Godelief
Smit, Filip
van Balkom, Anton
Spinhoven, Philip
Cuijpers, Pim
author_facet Meulenbeek, Peter
Willemse, Godelief
Smit, Filip
van Balkom, Anton
Spinhoven, Philip
Cuijpers, Pim
author_sort Meulenbeek, Peter
collection PubMed
description BACKGROUND: Panic disorder (PD) is a common, severe and persistent mental disorder, associated with a high degree of distress and occupational and social disability. A substantial proportion of the population experiences subthreshold and mild PD and is at risk of developing a chronic PD. A promising intervention, aimed at preventing panic disorder onset and reducing panic symptoms, is the 'Don't Panic' course. It consists of eight sessions of two hours each. The purpose of this study is to evaluate the effectiveness of this early intervention – based on cognitive behavioural principles – on the reduction of panic disorder symptomatology. We predict that the experimental condition show superior clinical and economic outcomes relative to a waitlisted control group. METHODS/DESIGN: A pragmatic, pre-post, two-group, multi-site, randomized controlled trial of the intervention will be conducted with a naturalistic follow-up at six months in the intervention group. The participants are recruited from the general population and are randomized to the intervention or a waitlist control group. The intervention is offered by community mental health centres. Included are people over 18 years of age with subthreshold or mild panic disorder, defined as having symptoms of PD falling below the cut-off of 13 on the Panic Disorder Severity Scale-Self Report (PDSS-SR). Primary outcomes are panic disorder and panic symptoms. Secondary outcomes are symptoms of agoraphobia, anxiety, cognitive aspects of panic disorder, depressive symptoms, mastery, health-related quality of life, and cost-effectiveness. We will examine the following variables as potential mediators: cognitive aspects of panic disorder, symptoms of agoraphobia, anxiety and mastery. Potential moderating variables are: socio-demographic characteristics, panic disorder, agoraphobia, treatment credibility and mastery. DISCUSSION: This study was designed to evaluate the (cost) effectiveness of an early intervention based on cognitive behavioural principles. The strong external validity is one of the strengths of the study design. TRIAL REGISTRATION: Current Controlled Trials ISRCTN33407455.
format Text
id pubmed-2630960
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26309602009-01-27 Early intervention in panic: randomized controlled trial and cost-effectiveness analysis Meulenbeek, Peter Willemse, Godelief Smit, Filip van Balkom, Anton Spinhoven, Philip Cuijpers, Pim Trials Study Protocol BACKGROUND: Panic disorder (PD) is a common, severe and persistent mental disorder, associated with a high degree of distress and occupational and social disability. A substantial proportion of the population experiences subthreshold and mild PD and is at risk of developing a chronic PD. A promising intervention, aimed at preventing panic disorder onset and reducing panic symptoms, is the 'Don't Panic' course. It consists of eight sessions of two hours each. The purpose of this study is to evaluate the effectiveness of this early intervention – based on cognitive behavioural principles – on the reduction of panic disorder symptomatology. We predict that the experimental condition show superior clinical and economic outcomes relative to a waitlisted control group. METHODS/DESIGN: A pragmatic, pre-post, two-group, multi-site, randomized controlled trial of the intervention will be conducted with a naturalistic follow-up at six months in the intervention group. The participants are recruited from the general population and are randomized to the intervention or a waitlist control group. The intervention is offered by community mental health centres. Included are people over 18 years of age with subthreshold or mild panic disorder, defined as having symptoms of PD falling below the cut-off of 13 on the Panic Disorder Severity Scale-Self Report (PDSS-SR). Primary outcomes are panic disorder and panic symptoms. Secondary outcomes are symptoms of agoraphobia, anxiety, cognitive aspects of panic disorder, depressive symptoms, mastery, health-related quality of life, and cost-effectiveness. We will examine the following variables as potential mediators: cognitive aspects of panic disorder, symptoms of agoraphobia, anxiety and mastery. Potential moderating variables are: socio-demographic characteristics, panic disorder, agoraphobia, treatment credibility and mastery. DISCUSSION: This study was designed to evaluate the (cost) effectiveness of an early intervention based on cognitive behavioural principles. The strong external validity is one of the strengths of the study design. TRIAL REGISTRATION: Current Controlled Trials ISRCTN33407455. BioMed Central 2008-11-27 /pmc/articles/PMC2630960/ /pubmed/19038038 http://dx.doi.org/10.1186/1745-6215-9-67 Text en Copyright © 2008 Meulenbeek et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Meulenbeek, Peter
Willemse, Godelief
Smit, Filip
van Balkom, Anton
Spinhoven, Philip
Cuijpers, Pim
Early intervention in panic: randomized controlled trial and cost-effectiveness analysis
title Early intervention in panic: randomized controlled trial and cost-effectiveness analysis
title_full Early intervention in panic: randomized controlled trial and cost-effectiveness analysis
title_fullStr Early intervention in panic: randomized controlled trial and cost-effectiveness analysis
title_full_unstemmed Early intervention in panic: randomized controlled trial and cost-effectiveness analysis
title_short Early intervention in panic: randomized controlled trial and cost-effectiveness analysis
title_sort early intervention in panic: randomized controlled trial and cost-effectiveness analysis
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630960/
https://www.ncbi.nlm.nih.gov/pubmed/19038038
http://dx.doi.org/10.1186/1745-6215-9-67
work_keys_str_mv AT meulenbeekpeter earlyinterventioninpanicrandomizedcontrolledtrialandcosteffectivenessanalysis
AT willemsegodelief earlyinterventioninpanicrandomizedcontrolledtrialandcosteffectivenessanalysis
AT smitfilip earlyinterventioninpanicrandomizedcontrolledtrialandcosteffectivenessanalysis
AT vanbalkomanton earlyinterventioninpanicrandomizedcontrolledtrialandcosteffectivenessanalysis
AT spinhovenphilip earlyinterventioninpanicrandomizedcontrolledtrialandcosteffectivenessanalysis
AT cuijperspim earlyinterventioninpanicrandomizedcontrolledtrialandcosteffectivenessanalysis